Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 44501 - 44525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Fulvestrant	Approved Investigational	SGK3	23678	downregulated	fulvestrant results in decreased expression of SGK3 mRNA	8q13.1	A21106
Fulvestrant	Approved Investigational	SIAH2	6478	downregulated	fulvestrant results in decreased expression of SIAH2 mRNA	3q25.1	A21106
Fulvestrant	Approved Investigational	SLC26A2	1836	downregulated	fulvestrant results in decreased expression of SLC26A2 mRNA	5q32	A20479
Fulvestrant	Approved Investigational	SLC39A6	25800	downregulated	fulvestrant results in decreased expression of SLC39A6 mRNA	18q12.2	A20479
Fulvestrant	Approved Investigational	SLC7A5	8140	downregulated	fulvestrant results in decreased expression of SLC7A5 mRNA	16q24.2	A21106
Fulvestrant	Approved Investigational	SMOX	54498	downregulated	fulvestrant results in decreased expression of SMOX mRNA	20p13	A21106
Fulvestrant	Approved Investigational	SOD1	6647	upregulated	fulvestrant results in increased expression of SOD1 mRNA	21q22.11	A20482
Fulvestrant	Approved Investigational	SON	6651	downregulated	fulvestrant results in decreased expression of SON mRNA	21q22.11	A20479
Fulvestrant	Approved Investigational	SRSF1	6426	downregulated	fulvestrant results in decreased expression of SRSF1 mRNA	17q22	A20479
Fulvestrant	Approved Investigational	SSBP2	23635	upregulated	fulvestrant results in increased expression of SSBP2 mRNA	5q14.1	A21106
Fulvestrant	Approved Investigational	STAT1	6772	downregulated	fulvestrant results in decreased expression of STAT1 mRNA	2q32.2	A20479
Fulvestrant	Approved Investigational	STK26	51765	downregulated	fulvestrant results in decreased expression of STK26 mRNA	Xq26.2	A20479
Fulvestrant	Approved Investigational	STMN1	3925	downregulated	fulvestrant results in decreased expression of STMN1 mRNA	1p36.11	A20479
Fulvestrant	Approved Investigational	SVIL	6840	downregulated	fulvestrant results in decreased expression of SVIL mRNA	10p11.23	A21106
Fulvestrant	Approved Investigational	TACC1	6867	upregulated	fulvestrant results in increased expression of TACC1 mRNA	8p11.22	A21102 A20493
Fulvestrant	Approved Investigational	TAF9	6880	downregulated	fulvestrant results in decreased expression of TAF9 mRNA	5q13.2	A20479
Fulvestrant	Approved Investigational	TAF9	6880	upregulated	fulvestrant results in increased expression of TAF9 mRNA	5q13.2	A20482
Fulvestrant	Approved Investigational	TARS	6897	downregulated	fulvestrant results in decreased expression of TARS mRNA	5p13.3	A20479
Fulvestrant	Approved Investigational	TCF19	6941	downregulated	fulvestrant results in decreased expression of TCF19 mRNA	6p21.33	A22729
Fulvestrant	Approved Investigational	TERT	7015	downregulated	fulvestrant results in decreased expression of TERT mRNA alternative form	5p15.33	A21376
Fulvestrant	Approved Investigational	TFAP2A	7020	upregulated	fulvestrant results in increased expression of TFAP2A mRNA	6p24.3	A21106
Fulvestrant	Approved Investigational	TFAP2C	7022	downregulated	fulvestrant results in decreased expression of TFAP2C mRNA	20q13.31	A21106
Fulvestrant	Approved Investigational	TFF1	7031	downregulated	fulvestrant results in decreased expression of TFF1 mRNA	21q22.3	A22733 A21102 A21116 A20479 A21158 A22737
Fulvestrant	Approved Investigational	TFF2	7032	downregulated	fulvestrant results in decreased expression of TFF2 mRNA	21q22.3	A21195
Fulvestrant	Approved Investigational	TFF3	7033	downregulated	fulvestrant results in decreased expression of TFF3 mRNA	21q22.3	A21116

Displaying entries 44501 - 44525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability